These results provide compelling evidence for a neuroprotective role of THOP1 against toxic effects of A-beta in the early stages of AD pathology, and suggest that the observed increase in THOP1 expression might be part of a compensatory defense mechanism of the brain against an increased A-beta load [150]. The gene discussed is THOP1; the disease is Alzheimer disease.